News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Vertex Pharmaceuticals
NEWS
JOBS
IN THE PRESS
NEWS
Genetown
The Day In Review: News From The Hepatitis Front
October 27, 2006
·
1 min read
Biotech Beach
Vertex Pharmaceuticals Incorporated And The Hepatitis C Hope
September 7, 2006
·
1 min read
Biotech Beach
The Day In Review: Revlimid Approved For Multiple Myeloma
June 30, 2006
·
1 min read
Biotech Beach
The Day In Review: Vertex Pharmaceuticals Incorporated Reveals Positive Hep C Data
May 22, 2006
·
1 min read
Biotech Beach
The Day In Review: Biotechs Update Hepatitis C News
May 1, 2006
·
1 min read
Biotech Beach
The Day In Review: SuperGen, Inc. Drug Disappoints
April 26, 2006
·
1 min read
Biotech Beach
The Day In Review: Vertex Reports Positive Cancer Drug Data
April 6, 2006
·
1 min read
Biotech Beach
The Day In Review: Novartis Corporation Inlicenses Idenix Pharmaceuticals, Inc. Drug For $525 Million
March 29, 2006
·
1 min read
Biotech Beach
The Day In Review: Vertex Pharmaceuticals Incorporated Reports Positive Arthritis Drug News
March 9, 2006
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Genetown
Vertex Pharmaceuticals (MA) Announces Webcast of its Presentation at the Goldman, Sachs & Co. 34th Annual Global Healthcare Conference
June 6, 2013
·
1 min read
Genetown
Vertex Pharmaceuticals (MA) Calls for Redemption of $400 Million in Convertible Senior Subordinated Notes Due 2015
May 17, 2013
·
1 min read
Genetown
Vertex Pharmaceuticals (MA) CFO Rings Register on $35 Million Insider Sale
April 24, 2013
·
1 min read
Business
Vertex Pharmaceuticals (MA) to Report First Quarter 2013 Financial Results on Tuesday, April 30
April 2, 2013
·
1 min read
Drug Development
Vertex Pharmaceuticals (MA) Nails Mid-Stage Study for Influenza
March 4, 2013
·
1 min read
Genetown
Vertex Pharmaceuticals (MA) Release: Republic of Ireland Approves Funding for KALYDECO (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis, for People With a Specific Genetic Mutation (G551D)
February 1, 2013
·
1 min read
Business
Vertex Pharmaceuticals (MA) Reports Full-Year and Fourth Quarter 2012 Financial Results and Provides Updates on Key Development Programs
January 30, 2013
·
1 min read
Business
Vertex Pharmaceuticals (MA) to Report Fourth Quarter and Full Year 2012 Financial Results on Tuesday, January 29
January 16, 2013
·
1 min read
Genetown
Vertex Pharmaceuticals (MA) Release: National Health Service in England Funds KALYDECO (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis, for People With a Specific Genetic Mutation (G551D)
December 19, 2012
·
1 min read
FDA
Cystic Fibrosis Drug From Vertex Pharmaceuticals (MA) is Approved by Canadian Regulators
December 3, 2012
·
10 min read
